0.052
0.00 (0.00%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (SG) | Bullish | Bearish |
| Medical Care Facilities (Global) | Bullish | Bearish | |
| Stock | Thomson Medical | - | - |
Analyst Consensus
2 Buy
Avg. Price @ Call: 0.052
Similar Stocks
| Stock | Market Cap | DY | P/E | P/B |
|---|---|---|---|---|
| THOMSON MEDICAL | 1 B | 0.77% | - | 2.83 |
| IHH | 15 B | 1.44% | 17.40 | 1.88 |
| RAFFLES MEDICAL | 2 B | 3.73% | 20.40 | 1.86 |
| OUE HEALTHCARE | 116 M | - | - | 0.540 |
| MEDILIFESTYLE | 1 M | - | - | - |
| TALKMED | 493 M | 5.95% | 18.50 | 5.92 |
|
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Mid Core |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Lim (Eng Hock) | 29 Aug 2023 | 23,745,523,527 (89.81%) |
| Ng (Ser Miang) | 21 Jul 2023 | 15,600,000 (0.06%) |
| 52 Weeks Range |
0.050 - 0.066
|
|
| Price Target Range | ||
| High | 0.080 (Maybank Research, 53.85%) | Buy |
| Median | 0.073 (40.38%) | |
| Low | 0.066 (Phillip Securities, 26.92%) | Buy |
| Average | 0.073 (40.38%) | |
| Total | 2 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Phillip Securities | 25 Mar 2024 | 0.066 (26.92%) | Buy | 0.052 |
| Maybank Research | 27 Feb 2024 | 0.080 (53.85%) | Buy | 0.052 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| Christina Teo Tze Wei | - | - | 0 | 0 |
| Aggregate Net Quantity | 0 | |||
| Aggregate Net Value ($) | 0 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| Christina Teo Tze Wei | Director | 09 May 2024 | Others | 500,000 | - | - |
| Date | Type | Details |
|---|---|---|
| 13 May 2024 | Announcement | General Announcement::Issuance of S$155mil 5.25% Notes Due 2027 |
| 09 May 2024 | Announcement | Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of changes in interest of Director |
| 07 May 2024 | Announcement | General Announcement::Upsize of 5.25% Notes Due 2027 from S$140mil to S$155mil |
| 06 May 2024 | Announcement | General Announcement::Launch of S$140mil 5.25% Notes Due 2027 |
| 04 Apr 2024 | Announcement | General Announcement::Restoration of Public Float |
| 04 Apr 2024 | TheEdge | Thomson Medical restores public float with sale of 50 mil shares |
| 22 Feb 2024 | Announcement | General Announcement::Change of Share Registrar |
| 19 Feb 2024 | Announcement | General Announcement::1H FY2024 Results Briefing - Presentation Deck |
| TTM Dividend Yield | 0.77% |
| 5Y Average Dividend Yield | 0.68% |
| Expected Next Dividend Payment | Nov 2024 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 24 Oct 2023 | 26 Sep 2023 | 03 Nov 2023 | 0.0004 Cash |
| 07 Nov 2022 | 14 Oct 2022 | 17 Nov 2022 | 0.00115 Cash |
| 02 Nov 2021 | 11 Oct 2021 | 12 Nov 2021 | 0.00015 Cash |
| 14 May 2019 | 01 Mar 2019 | 28 May 2019 | 0.00025 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2023 | 0.000 | 1 | 0.66 |
| 2022 | 0.001 | 1 | 1.47 |
| 2021 | 0.000 | 1 | 0.18 |
| 2019 | 0.000 | 1 | 0.39 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |